Top Upgrades

  • Argus Research upgraded Amgen, Inc. AMGN from Hold to Buy. Amgen shares rose 0.15 percent to $192.62 in pre-market trading.
  • Wells Fargo upgraded Dollar General Corp. DG from Market Perform to Outperform. Dollar General rose 0.75 percent to $103.04 in pre-market trading.
  • Analysts at Credit Suisse upgraded Duke Energy Corp DUK from Neutral to Outperform. Duke Energy shares rose 0.32 percent to $77.20 in pre-market trading.
  • SunTrust Robinson Humphrey upgraded Crispr Therapeutics AG CRSP from Hold to Buy. CRISPR Therapeutics shares gained 7.82 percent to $36.39 in pre-market trading.
  • Analysts at Mizuho upgraded Exelon Corporation EXC from Underperform to Neutral. Exelon shares gained 0.92 percent to $38.40 in pre-market trading.
  • Analysts at Barclays upgraded Altice USA Inc ATUS from Equal-Weight to Overweigh. Altice USA shares rose 3.42 percent to $22.65 in pre-market trading.
  • Morgan Stanley upgraded NetApp Inc. NTAP from Underweight to Equal-Weight. NetApp shares gained 0.68 percent to close at $63.52 on Monday.
  • Analysts at KeyBanc upgraded Central Garden & Pet Co CENT from Sector Weight to Overweight. Central Garden shares rose 0.24 percent to close at $37.82 on Monday.
  • Stifel Nicolaus upgraded Axcelis Technologies Inc ACLS from Hold to Buy. Axcelis Technologies shares rose 2.5 percent to $26.65 in pre-market trading.
  • Piper Jaffray upgraded Triumph Bancorp Inc TBK from Neutral to Overweight. Triumph Bancorp shares rose 2.78 percent to close at $37.00 on Monday.


Top Downgrades

  • Analysts at Deutsche Bank downgraded Arista Networks Inc ANET from Buy to Hold. Arista shares fell 2.17 percent to $269.70 in pre-market trading.
  • Morgan Stanley downgraded HP Inc HPQ from Overweight to Equal-Weight. HP shares fell 1.05 percent to $23.60 in pre-market trading.
  • Keefe Bruyette & Woods downgraded Validus Holdings, Ltd. VR from Outperform to Market Perform. Validus shares climbed 44.03 percent to close at $67.29 on Monday.
  • Mizuho downgraded Southern Co SO from Buy to Neutral. Southern shares fell 0.43 percent to $43.85 in pre-market trading.
  • Barclays downgraded Sanofi SA (ADR) SNY from Equal-Weight to Underweight. Sanofi shares gained 1.23 percent to $43.73 in pre-market trading.
  • Morgan Stanley downgraded GoPro Inc GPRO from Equal-Weight to Underweight. GoPro shares dropped 7 percent to $5.86 in pre-market trading.
  • Macquarie downgraded Sprint Corp S from Neutral to Underperform. Sprint shares fell 0.94 percent to $5.27 in pre-market trading.
  • Analysts at SunTrust Robinson Humphrey downgraded Juno Therapeutics Inc JUNO from Buy to Hold. Juno Therapeutics shares fell 0.35 percent to $85.70 in pre-market trading.
  • DA Davidson downgraded NetApp Inc. NTAP from Buy to Neutral. NetApp shares rose 0.25 percent to $63.68 in pre-market trading.
  • Jefferies downgraded Bioverativ Inc BIVV from Buy to Hold. Bioverativ shares climbed 61.89 percent to close at $103.79 on Monday.


Top Initiations

  • Buckingham initiated coverage on Navistar International Corp NAV with a Neutral rating. The price target for Navistar is set to $48. Navistar shares closed at $44.75 on Monday.
  • DA Davidson initiated coverage on Jack Henry & Associates, Inc. JKHY with a Neutral rating. The price target for Jack Henry is set to $118. Jack Henry shares closed at $125.32 on Monday.
  • Deutsche Bank initiated coverage on Mobile Mini Inc MINI with a Hold rating. The price target for Jack Henry is set to $39. Mobile Mini shares closed at $36.90 on Monday.
  • Analysts at UBS initiated coverage on Lennox International Inc. LII with a Neutral rating. Lennox shares closed at $215.62 on Monday.
  • Analysts at Stifel Nicolaus initiated coverage on Simply Good Foods Co SMPL with a Buy rating. The price target for Simply Good Foods is set to $16. Simply Good Foods shares closed at $14.13 on Monday.
  • William Blair initiated coverage on Global Blood Therapeutics Inc GBT with an Outperform rating. The price target for Global Blood Therapeutics is set to $80. Global Blood Therapeutics shares closed at $56.35 on Monday.
  • UBS initiated coverage on 3M Co MMM with a Neutral rating. 3M shares closed at $247.30 on Monday.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!